The cryopreservation of ovarian tissue has recently become one of the well established and accepted methods of protecting patient fertility where a patient is required to undergo radiotherapy and/or chemotherapy for treatment of a malignant tumour, and where this individual still wishes to have children.
During product development and design, there is a high risk of potential biological contamination. For our products in production, we perform tests, as well as other procedures, to check the sterility of raw materials and the finished end products and are thus able to safely prove that the products satisfy the requirements of a sterile product.
Studies have shown that many cryo tanks in IVF clinics are contaminated.Bielański et. al. (2003) demonstrated contamination by micro-organisms in both the liquid nitrogen and in the specimens. Criado et al. (2011) proved that micro-organisms are able to penetrate the liquid nitrogen in the specimen receptacles.